Danshen Injection for 5-Fluorouracil-Resistant Gastric Cancer: Mitochondrial Apoptosis and Enhanced Drug Activity
Journal of Visualized Experiments · 2026
DOI: 10.3791/72391 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2026. Written by Weiting Li and 9 co-authors. Institution: Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine. Major MEDLINE topics: Stomach Neoplasms, Fluorouracil, Mitochondria, Salvia miltiorrhiza.
Abstract (original language)
Gastric cancer ranks among the leading causes of cancer-related death worldwide, and the progressive emergence of 5-fluorouracil (5-FU) resistance represents a critical barrier to the efficacy of conventional chemotherapy, particularly 5-FU-based regimens. Danshen injection (DI), a clinically approved intravenous preparation derived from Salvia miltiorrhiza, has demonstrated preliminary antineoplastic activity; however, the mechanistic basis underlying its reversal of 5-FU resistance in gastric cancer has not been systematically defined. This study aimed to evaluate the antitumor efficacy of DI and its potential for enhanced combined activity with 5-FU in human gastric cancer cell lines (SGC7901 and BGC823), their 5-FU-resistant variants, and a xenograft mouse model. DI significantly induced apoptosis in both parental and drug-resistant cell lines, while CCK-8 assays confirmed markedly elevated IC50 values in resistant variants, validating the chemoresistant phenotype. The combination of DI and 5-FU produced enhanced antitumor effects superior to either agent alone, as demonstrated by increased apoptotic rates, upregulated expression of cleaved PARP and cleaved caspase-3, impaired mitochondrial membrane potential by JC-10 assay, and reduced colony formation. Mechanistically, DI promoted cytochrome c translocation from mitochondria to the cytoplasm, and elevated cleaved caspase-9 levels, effects that were further amplified upon co-treatment with 5-FU. Consistent antitumor activity was validated in vivo, with the combination regimen demonstrating superior tumor suppression compared with monotherapy. Collectively, these findings demonstrate that DI exerts meaningful antitumor activity and produces a greater combined effect with 5-FU in 5-FU-resistant gastric cancer. This study provides a preclinical rationale for incorporating DI into chemotherapy-based strategies for the management of 5-FU-resistant gastric cancer.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine.
- Department of General Surgery, Institute of Chinese Medicine Surgery.
- Department of General Surgery, Institute of Chinese Medicine Surgery; qsy6312@163.com.
- Department of General Surgery, Institute of Chinese Medicine Surgery; panhaozhi2000@126.com.
Cite
APA
Li, W., Peng, H., Shen, Y., Li, Z., Jin, L., Wang, Z., Jing, W., Yu, J., Yu, Q., & Pan, J. (2026). Danshen Injection for 5-Fluorouracil-Resistant Gastric Cancer: Mitochondrial Apoptosis and Enhanced Drug Activity. Journal of Visualized Experiments. https://doi.org/10.3791/72391
Vancouver
Li W, Peng H, Shen Y, Li Z, Jin L, Wang Z, et al. Danshen Injection for 5-Fluorouracil-Resistant Gastric Cancer: Mitochondrial Apoptosis and Enhanced Drug Activity. Journal of Visualized Experiments. 2026. doi:10.3791/72391
BibTeX
@article{Li2026,
author = {Li, Weiting and Peng, Hui and Shen, Yi and Li, Ziyi and Jin, Lei and Wang, Zhen and Jing, Wenshan and Yu, Jian and Yu, Qingsheng and Pan, Jinfang},
title = {Danshen Injection for 5-Fluorouracil-Resistant Gastric Cancer: Mitochondrial Apoptosis and Enhanced Drug Activity},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/72391}
}
EUVIMED